Moreover, Rag1−/− mice bearing B16 melanoma that received SIRT1-deficient CD4+T (Sirt1flox/floxCd4-Cre) cells exhibited smaller tumors compared with the WT mice that received CD4+T cells. Here, CD4 is linked to melanoma.